Magenta Lifecare (BOM:544188) Research & Development: ₹0.0 Mil (TTM As of Mar. 2026)


BOM:544188 Magenta Lifecare Ltd BOM:544188
33 GF Score
Price ₹9.40
! 7 Warning Signs
View Full Analysis

What is Magenta Lifecare Research & Development?

Magenta Lifecare BOM:544188 33 Research & Development is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:544188 with a GF Score™ of 33/100. The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Magenta Lifecare's Research & Development for the six months ended in Mar. 2026 was ₹0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil.

Magenta Lifecare  (BOM:544188) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Magenta Lifecare Research & Development Related Terms

Magenta Lifecare Research & Development Historical Data

* Premium members only.

The historical data trend for Magenta Lifecare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Magenta Lifecare Research & Development Chart

Magenta Lifecare Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Magenta Lifecare Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:544188
33GF Score
Magenta Lifecare Ltd BOM:544188
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Magenta Lifecare Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0.0 Mil mean?
Magenta Lifecare (BOM:544188) has a Research & Development of ₹0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Magenta Lifecare and its competitors.
Is Magenta Lifecare's Research & Development too high?
Magenta Lifecare's current Research & Development is ₹0.0 Mil. Overall, Magenta Lifecare has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Magenta Lifecare's Research & Development compare to SN and SGI?
Magenta Lifecare's Research & Development of ₹0.0 Mil can be compared against companies in the Furnishings, Fixtures & Appliances industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Furnishings, Fixtures & Appliances company?
A good Research & Development depends on the Furnishings, Fixtures & Appliances industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Magenta Lifecare and its competitors. Magenta Lifecare's current Research & Development is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Magenta Lifecare stock overvalued right now?
Magenta Lifecare (BOM:544188) has a current Research & Development of ₹0.0 Mil. The current Research & Development is ₹0.0 Mil. Magenta Lifecare's overall GF Score™ is 33/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Magenta Lifecare (BOM:544188), the current Research & Development is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Magenta Lifecare Business Description

Address National Highway No.48, N.P.Patel Estate, Vadodara, GJ, IND, 391350
Magenta Lifecare Ltd is a manufacturer, seller, and service provider of foam-based products such as mattresses and pillows, marketed under the brand Magenta in India. It offers products including memory foam, latex-based, bonded mattresses, pocketed springs, and pillows such as memory foam pillows, molded memory foam pillows, and molded contour foam pillows.
33GF Score

Get the complete analysis for BOM:544188

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹9.40
Price